Exceptional pathologic response to preoperative therapy in the context of mutational profiling for colorectal liver metastases

J Gastrointest Surg. 2024 May 7:S1091-255X(24)00443-8. doi: 10.1016/j.gassur.2024.05.002. Online ahead of print.

Authors

Mateo Lendoire¹, Harufumi Maki¹, Antony Haddad¹, Timothy E Newhook¹, Ching-Wei D Tzeng¹, Jean-Nicolas Vauthey¹, Hop S Tran Cao²

Affiliations

¹ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
² Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States. Electronic address: hstran@mdanderson.org.

PMID: 38723997
DOI: 10.1016/j.gassur.2024.05.002

No abstract available

Keywords: Colorectal liver metastases; Exceptional pathologic response; Pathologic response; Preoperative chemotherapy.